Concepedia

Gary M. Karp

GM

Statistics

Publications

23

Citations

2.4K

H-Index

17

Active since

1983

Affiliations

PTC Therapeutics (United States)(Current)

Merck & Co., Inc., Rahway, NJ, USA (United States)

Roche (Switzerland)

University of Southern California

Harvard University

Gary M. Karp is an author at PTC Therapeutics (United States) specializing in medicinal chemistry, drug discovery, and pharmacology.

Publications per year

1983–2022

23

Publications

23

PTC124 targets genetic disorders caused by nonsense mutations

Ellen Welch, Elisabeth R. Barton, Jin Zhuo et al. · Nature · 2007 · 1.1K citations

, , +8

<i>SMN2</i> splicing modifiers improve motor function and longevity in mice with spinal muscular atrophy

Nikolai A. Naryshkin, Marla Weetall, Amal Dakka et al. · Science · 2014 · 526 citations

, , +17

Specific Correction of Alternative Survival Motor Neuron 2 Splicing by Small Molecules: Discovery of a Potential Novel Medicine To Treat Spinal Muscular Atrophy

Hasane Ratni, Gary M. Karp, Marla Weetall et al. · Journal of Medicinal Chemistry · 2016 · 113 citations

, , +14

Small molecule splicing modifiers with systemic HTT-lowering activity

Anuradha Bhattacharyya, Christopher R. Trotta, Jana Narasimhan et al. · Nature Communications · 2021 · 85 citations · Full text

, , +17

Microvascular heparin-like species with anticoagulant activity

James A. Marcum, Linda M.S. Fritze, SJ Galli et al. · American Journal of Physiology-Heart and Circulatory Physiology · 1983 · 65 citations

, , +13

1–5 of 23